26 completed, 2 unknown, 1 active not recruiting, 1 recruiting. 12 Not applicable, 5 Phase 3, 5 Phase 4, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 12 | Completed 10, Active not recruiting 1, Withdrawn 1 |
| Phase 3 | 5 | Completed 3, Terminated 1, Unknown 1 |
| Phase 4 | 5 | Completed 4, Unknown 1 |
| Phase 2 | 4 | Completed 3, Terminated 1 |
Follow Substance Abuse, Intravenous: new trials by email Literature Review of Substance Abuse, Intravenous trials Research Report on Substance Abuse, Intravenous
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Cross-Sectional Observational Study on Retained Drug Needle Fragments in People Who Use Intravenous Drugs Low-dose X-ray of subcutaneous tissues - Drug Abuse, Intravenous, Substance Dependence | Recruiting | Tampere University Hospital | 100 | 2023-05-25 | 2023-06-01 | |
| Telemedicine and Social Media for People Who Inject Drugs (PWID) in Greece Focus group discussions and survey questionnaire - Drug Abuse, Intravenous, Internet | Completed | State University of New York at Buffalo | 219 | 2023-05-02 | 2024-02-05 | |
| Implementing PrEP for Women Who Inject Drugs Practice Facilitation - HIV, Intravenous Substance Abuse | Not applicable | Active not recruiting | University of Pennsylvania | 130 | 2021-06-22 | 2026-10-21 |
| Substance Use Disorder (SUD)-Associated Infections' Treatment With Dalbavancin ENabling OUtpatient Transition Dalbavancin - Gram-Positive Bacterial Infections, Gram-Positive Bacteraemia | Phase 2 / Phase 3 | Terminated | University of Colorado, Denver | 11 | 2021-04-30 | 2023-10-19 |
| Pre-exposure Prophylaxis (PrEP) for People Who Inject Drugs (PWID) PrEP uptake/adherence intervention, Harm reduction standard of care - Intravenous Drug Abuse | Not applicable | Withdrawn | Boston University | 2021-03-01 | 2021-03-10 | |
| Non-Invasive Vagal Nerve Stimulation in Opioid Use Disorders Non invasive VN stimulation (nVNS), Oxygen (15-O) Water, Sham Stimulation - Substance-Related Disorders, Substance Use Disorders | Phase 3 | Completed | Emory University | 20 | 2020-11-13 | 2023-09-13 |
| Hepatitis C Treatment in PWIDs: MAT or Syringe Exchange Assisted-therapy vs Standard of Care elbasvir-grazoprevir (50 mg/100 mg) - Hepatitis C, Substance Use Disorders | Phase 4 | Completed | Oregon Health and Science University | 100 | 2017-05-30 | 2020-11-12 |
| BRIDGE: Improving HIV Service Delivery for People Who Inject Drugs BRIDGE - Human Immunodeficiency Virus, Substance Abuse, Intravenous | Not applicable | Completed | Columbia University | 616 | 2017-02-01 | 2022-05-31 |
| PWID; Longitudinal S Aureus Colonization Pattern and the Impact on Infection Frequency by Regular Showers With Chlorhexidine Chlorhexidine Topical - Intravenous Drug Abuse, S Aureus Colonization | Phase 4 | Completed | Lund University | 61 | 2016-12-15 | 2022-04-28 |
| Break the Cycle: Prevention for Reducing Initiation Into Injection Drug Use Break the Cycle Intervention, Bacterial Infection Prevention - Substance Abuse, Intravenous, Prevention and Control | Not applicable | Completed | New York University | 402 | 2016-08-31 | 2025-05-25 |
| Case Management in HCV Infected PWID case management - Drug Abuse, Intravenous | Not applicable | Completed | Hasselt University | 441 | 2016-07-01 | 2020-01-27 |
| Change the Cycle: An RCT to Prevent Injection Initiation Change the Cycle - Substance Abuse, Intravenous, HIV | Not applicable | Completed | University of Southern California | 979 | 2016-06-01 | 2023-03-20 |
| Conflict Between Maternal Autonomy and Child Health in Substance-use Substance-Related Disorders, Alcohol-Related Disorders | Completed | London School of Hygiene and Tropical Medicine | 6 | 2016-05-01 | 2016-09-08 | |
| The Long-Term Treatment of Drug Addiction and Unemployment Abstinence-contingent wage supplements, Individual Placement and Support (IPS) supported employment - Substance Abuse, Intravenous | Not applicable | Completed | Johns Hopkins University | 91 | 2015-11-01 | 2022-08-11 |
| Therapy With Ledipasvir/Sofosbuvir in Patients With Genotype 1 HCV Infection Receiving Opiate Substitution Therapy Sofosbuvir 400mg / Ledipasvir 90 mg (FDC) - Chronic Hepatitis C | Phase 4 | Unknown | Wilhelminenspital Vienna | 40 | 2015-09-01 | 2015-12-23 |
| Stage III Community-based Efficacy Trial for Mothering From the Inside Out Mothering From the Inside Out (MIO), Parent Education - Addiction, Substance Abuse Drug Chronic | Not applicable | Completed | Yale University | 97 | 2015-04-01 | 2021-07-14 |
| The TAP Study: Treating People Who Inject Drugs in Community-Based Settings Using a Social Network Approach Sofosbuvir/ledispasvir fixed dose combination (SOF + LDP) - Hepatitis C, Drug Abuse, Intravenous | Phase 3 | Unknown | Macfarlane Burnet Institute for Medical Research and Public Health Ltd | 420 | 2015-02-01 | 2018-04-10 |
| : Bacterial Infections in Injecting Drug Users Bacterial Infection | Completed | University Hospital, Montpellier | 117 | 2012-01-17 | 2020-09-18 | |
| Contingency Management in the Delivery of HAART to Drug Users in Chennai, India Contingency, Prize bowl drawings - HIV, Substance Abuse, Intravenous | Phase 2 | Completed | Johns Hopkins University | 120 | 2011-05-01 | 2016-11-02 |
| Effectiveness of Buprenorphine/Naloxone in Reducing Intravenous Buprenorphine Misuse in France ("RIME") Buprenorphine (Subutex), Buprenorphine/naloxone (Suboxone) - Opioid Dependency | Phase 4 | Completed | Indivior Inc. | 270 | 2009-08-01 | 2012-11-30 |
Showing 20 of 32. Sign in to see all of them.
Opioid-Related Disorders (8) · Substance-Related Disorders (8) · Hepatitis C (5) · Heroin Dependence (5) · Cocaine-Related Disorders (4) · HIV Infections (4) · Amphetamine-Related Disorders (3) · Hepatitis C, Chronic (3) · Bacterial Infections (2) · Risk-Taking (2) · Acquired Immunodeficiency Syndrome (1) · Adherence Interventions (1) · Alcohol-Related Disorders (1) · Attention Deficit Disorder with Hyperactivity (1)
Chemically-Induced Disorders (32) · Mental Disorders (32) · Substance-Related Disorders (24) · Infections (13) · Blood-Borne Infections (11) · Communicable Diseases (11) · RNA Virus Infections (11) · Virus Diseases (11) · Narcotic-Related Disorders (8) · Digestive System Diseases (7) · Flaviviridae Infections (7) · Hepatitis, Viral, Human (7) · Liver Diseases (7) · Behavior (6) · Hepatitis (6)
Buprenorphine (3) · Sofosbuvir (2) · Buprenorphine, Naloxone Drug Combination (1) · Case Management (1) · Chlorhexidine (1) · Community-Institutional Relations (1) · Employment, Supported (1) · Engerix-B (1) · Lisdexamfetamine Dimesylate (1) · Myo-Inositol-1-Phosphate Synthase (1) · Naloxone (1) · Needle-Exchange Programs (1) · Oxygen (1) · Oxygen-15 (1) · Palliative Care (1)
Johns Hopkins University (4) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Yale University (2) · Boston University (1) · Columbia University (1) · Emory University (1) · Hasselt University (1) · Indivior Inc. (1) · London School of Hygiene and Tropical Medicine (1) · Lund University (1) · Macfarlane Burnet Institute for Medical Research and Public Health Ltd (1) · Merck Sharp & Dohme LLC (1) · New River Pharmaceuticals (1) · New York State Psychiatric Institute (1) · New York University (1)
United States (18) · France (2) · Thailand (2) · Australia (1) · Austria (1) · Belgium (1) · Estonia (1) · Finland (1) · Greece (1) · India (1) · Kazakhstan (1) · United Kingdom (1)
Kenneth Silverman, Ph.D. (2) · Andrew Talal, MD (1) · Angela Bazzi, PhD, MPH (1) · Anneli Uuskula, PhD (1) · Atif Zaman, MD (1) · Buchbinder S (1) · Carl Latkin, PhD (1) · Celum C (1) · Chloe Knox (1) · Don Des Jarlais, PhD (1) · Donald Jasinski, MD (1) · Erik W. Gunderson, M.D. (1) · Geert Robaeys, prof. dr. (1) · Heidi Laukkala, MD (1)
PMID 16183464, PMID 16870915, PMID 17933486, PMID 17970256, PMID 17980513, PMID 18233994, PMID 19149819, PMID 20079620, PMID 20425880, PMID 21241735, PMID 23205722, PMID 23362861, PMID 23616960, PMID 23884067, PMID 23884071, PMID 23884073, PMID 24803381, PMID 25134047, PMID 26005037, PMID 29316001, PMID 31200757, PMID 32086373, PMID 34416867, PMID 36041704, PMID 36454567, PMID 37932493, PMID 38249543, PMID 39425182, PMID 40045378, PMID 40211324, PMID 40548916, PMID 40784774, PMID 40833692
5DP1DA039542-05 (1), K01DA043412 (1), K01DA051348 (1), K23DA020000 (1), R01DA009803 (1), R01DA012564 (1), R01DA017294 (1), R01DA017476 (1), R01DA018577 (1), R01DA019386 (1), R01DA037314 (1), R01DA038965 (1), R01DA041063 (1), UG3DA048502 (1)